Vergent Bioscience, Inc.
3 clinical trials · Sponsor
◉ Watch Vergent Bioscience, Inc.
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung (NCT07499674) | Vergent Bioscience, Inc. | 2026-03-31 |
| Phase 2 Study of VGT-309 in Lung Cancer (NCT05400226) | Vergent Bioscience, Inc. | 2022-05-24 |
Track Vergent Bioscience, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.